Form D · Biotechnology
PRECISION BIOSCIENCES INC
Durham, NC · CIK 0001357874
Offering snapshot reported Mar 15, 2019 · SEC filing
- Reported sold
- $39.6M Offering amount: $70M
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 1, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 15, 2019 | Initial | $39,550,000 | No comparison | 23 | SEC filing |
| Jun 8, 2018 | Initial | $88,075,013 | No comparison | 40 | SEC filing |
| May 12, 2015 | Initial | $25,650,000 | No comparison | 11 | SEC filing |
| Mar 15, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-335011
Source: Form D, filed Mar 15, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Adelman | Director |
| Abid Ansari | Executive |
| Ben Auspitz | Director |
| Derek Jantz | Director, Executive |
| Matthew Kane | Director, Executive |
| Todd Melby | Executive |
| Shalini Sharp | Director |
| Jeff Smith | Executive |
| Tony Yao | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
302 East Pettigrew Street Suite A 100
Durham, NC, 27701
Durham, NC, 27701